Racial grouping

From Wikipedia, the free encyclopedia

Please help improve this article or section by expanding it. Further information might be found on the talk page or at requests for expansion.

It has been suggested that this article or section be merged into Race in biomedicine. (Discuss)

There is an active debate among biomedical researchers about the meaning and importance of race in their research. The primary impetus for considering race in biomedical research is the possibility of improving the prevention and treatment of diseases by predicting hard-to-ascertain factors on the basis of more easily ascertained characteristics. The most well-known examples of genetically-determined disorders that vary in incidence between ethnic groups would be sickle cell disease among black populations, thalassaemia among Mediterranean populations, and Tay-Sachs disease among people of Ashkenazi Jewish descent. Some fear that the use of racial labels in biomedical research runs the risk of unintentionally exacerbating health disparities, so they suggest alternatives to the use of racial taxonomies.